Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy

A Plückthun - Annual review of pharmacology and toxicology, 2015 - annualreviews.org
Designed ankyrin repeat proteins (DARPins) can recognize targets with specificities and
affinities that equal or surpass those of antibodies, but because of their robustness and …

Arming antibodies: prospects and challenges for immunoconjugates

AM Wu, PD Senter - Nature biotechnology, 2005 - nature.com
Immunoconjugates—monoclonal antibodies (mAbs) coupled to highly toxic agents,
including radioisotopes and toxic drugs (ineffective when administered systemically alone) …

Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides

S Liu - Advanced drug delivery reviews, 2008 - Elsevier
Receptor-based radiopharmaceuticals are of great current interest in molecular imaging and
radiotherapy of cancers, and provide a unique tool for target-specific delivery of …

CORM‐A1: a new pharmacologically active carbon monoxide‐releasing molecule

R Motterlini, P Sawle, S Bains, J Hammad… - The FASEB …, 2005 - Wiley Online Library
Carbon monoxide (CO) is emerging as an important and versatile mediator of physiological
processes to the extent that treatment of animals with exogenous CO gas has beneficial …

Synthesis and Properties of Boranocarbonate:  A Convenient in Situ CO Source for the Aqueous Preparation of [99mTc(OH2)3(CO)3]+

R Alberto, K Ortner, N Wheatley, R Schibli… - Journal of the …, 2001 - ACS Publications
The recently described technetium (I) complex [99mTc (OH2) 3-(CO) 3]+ 1 has attracted
much interest as a precursor for technetium-99m radiopharmaceuticals. 1 A number of …

Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era

MD Bartholoma, AS Louie, JF Valliant… - Chemical …, 2010 - ACS Publications
The objective of medical imaging using molecular probes and perfusion radiotracers is to
provide rapid, noninvasive evaluation of physiology, pathology, and/or organ function. The …

Antibody engineering

J Maynard, G Georgiou - Annual review of biomedical …, 2000 - annualreviews.org
▪ Abstract Antibodies are unique in their high affinity and specificity for a binding partner, a
quality that has made them one of the most useful molecules for biotechnology and …

Early phase I study of a 99mTc-labeled anti–programmed death ligand-1 (PD-L1) single-domain antibody in SPECT/CT assessment of PD-L1 expression in non–small …

Y **ng, G Chand, C Liu, GJR Cook… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Immunotherapy with checkpoint inhibitor programmed cell death 1 (PD-1)/programmed
death ligand-1 (PD-L1) antibodies demonstrates improvements in treatment of advanced …

Antibodies and genetically engineered related molecules: production and purification

ACA Roque, CR Lowe, MÂ Taipa - Biotechnology progress, 2004 - Wiley Online Library
Antibodies and antibody derivatives constitute 20% of biopharmaceutical products currently
in development, and despite early failures of murine products, chimeric and humanized …

Bioinspired thiophosphorodichloridate reagents for chemoselective histidine bioconjugation

S Jia, D He, CJ Chang - Journal of the American Chemical …, 2019 - ACS Publications
Site-selective bioconjugation to native protein residues is a powerful tool for protein
functionalization, with cysteine and lysine side chains being the most common points for …